answersLogoWhite

0

The patent for Simponi (golimumab) in the United States is set to expire in 2029. However, specific patent expiration dates can vary based on additional patents and regulatory exclusivities. It's important to check for any updates or changes in patent status, as this information can evolve over time.

User Avatar

AnswerBot

3d ago

What else can I help you with?